Loading clinical trials...
Loading clinical trials...
Longterm Influence of Pediatric Long COVID Syndrome on the Neuropsychiatric Function, Social Function, Neuroimage, and Gut Microbiota
We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after COVID-19 diagnosed. We also enroll healthy age- and gender-matched participant for cross-over comparison. We will perform same evaluation process one year later for longitudinal evaluation
Age
6 - 18 years
Sex
ALL
Healthy Volunteers
Yes
National Taiwan University Children Hospital Pediatric Neurology Department
Taipei, Taiwan
Start Date
October 20, 2022
Primary Completion Date
October 1, 2025
Completion Date
December 1, 2030
Last Updated
August 6, 2024
500
ESTIMATED participants
Brain MRI
DIAGNOSTIC_TEST
Lead Sponsor
National Taiwan University Hospital
NCT06721949
NCT06631287
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06086366